T
Tonghua Golden-Horse Pharmaceutical Industry Co Ltd
SZSE:000766
Tonghua Golden-Horse Pharmaceutical Industry Co Ltd
SZSE:000766
Price:
18.46
CNY
-12.22%
Market Closed
Market Cap:
¥17.8B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
T
|
Tonghua Golden-Horse Pharmaceutical Industry Co Ltd
SZSE:000766
|
CN |
|
R
|
Resilux NV
LSE:0FSN
|
BE |
|
Uex Corp
TSX:UEX
|
CA |
|
Kardemir Karabuk Demir Celik Sanayi ve Ticaret AS
IST:KRDMD.E
|
TR |
|
Immunocore Holdings PLC
NASDAQ:IMCR
|
UK |
|
I
|
Inter RAO Lietuva AB
WSE:IRL
|
LT |
|
B
|
Beiersdorf AG
XBER:BEI
|
DE |
|
S
|
Sionna Therapeutics Inc
NASDAQ:SION
|
US |
|
M
|
Makamer Holdings Inc
OTC:HWIN
|
US |
|
AVG Logistics Ltd
BSE:543910
|
IN |
|
Bank of Japan
TSE:8301
|
JP |
|
Thinker Agricultural Machinery Co Ltd
SSE:603789
|
CN |
|
Ten Pao Group Holdings Ltd
HKEX:1979
|
HK |
Relative Value
The Relative Value of one Tonghua Golden-Horse Pharmaceutical Industry Co Ltd stock under the Base Case scenario is hidden CNY. Compared to the current market price of 18.46 CNY, Tonghua Golden-Horse Pharmaceutical Industry Co Ltd is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Tonghua Golden-Horse Pharmaceutical Industry Co Ltd Relative Value
HIDDEN
Multiples Across Competitors
Competitors Multiples
Tonghua Golden-Horse Pharmaceutical Industry Co Ltd Competitors
Tonghua Golden-Horse Pharmaceutical Industry Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
T
|
Tonghua Golden-Horse Pharmaceutical Industry Co Ltd
SZSE:000766
|
17.8B CNY | 14.3 | 310.4 | 121.7 | 121.7 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
860.3B USD | 13.1 | 41.3 | 27.9 | 29.8 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
566.9B USD | 6 | 21.1 | 14.6 | 18 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
243.3B CHF | 3.9 | 18.8 | 11.2 | 12.6 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
213.1B GBP | 4.9 | 28 | 15.6 | 22 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
286.3B USD | 4.4 | 15.7 | 9.7 | 11.8 | |
| CH |
|
Novartis AG
SIX:NOVN
|
222.8B CHF | 5.1 | 20.7 | 12.8 | 16.5 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK | 3.4 | 10.3 | 7.6 | 8.9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
152.2B USD | 2.5 | 19.8 | 7.6 | 10.1 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
114.7B USD | 2.4 | 16.4 | 7 | 8.6 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
